Sharis Shabandari
Family · Dublin, OHNPI 1053896795
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 70.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $9,999 and has fallen 70.8% since, to $2,918 in 2025. Among family clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 355 payments — averaging $53.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$14K
- Inspire Medical Systems, Inc.$1K
- Harmony Biosciences LLC$1K
- Avadel CNS Pharmaceuticals, LLC$1K
- Axsome Therapeutics, Inc.$497
- Azurity Pharmaceuticals, Inc.$392
- plus $557 from 11 others
What the payments were for
- Consulting fees$3502%
- Speaking & faculty fees$7,32538%
- Travel & lodging$3,35418%
- Food & beverage$7,74841%
- Education$3472%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 147 | $13,523 |
| Inspire Medical Systems, Inc. | 24 | $1,462 |
| Harmony Biosciences LLC | 65 | $1,445 |
| Avadel CNS Pharmaceuticals, LLC | 41 | $1,249 |
| Axsome Therapeutics, Inc. | 31 | $497 |
| Azurity Pharmaceuticals, Inc. | 19 | $392 |
| Vanda Pharmaceuticals Inc. | 3 | $86 |
| Merck | 5 | $73 |
| Lilly USA, LLC | 3 | $68 |
| Noctrix Health, Inc. | 2 | $60 |
| Arbor Pharmaceuticals, Inc. | 4 | $58 |
| Eisai Inc. | 3 | $54 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| ZOLL Respicardia, Inc. | 2 | $37 |
| Resmed Corp | 1 | $33 |
| Medicomp Inc | 1 | $21 |
| Itamar Medical Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,124 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Oxybate | 14 | $217,303 |
| SunosiSolriamfetol Hcl | 19 | $16,172 |
| Armodafinil | 40 | $3,444 |
| Modafinil | 19 | $2,915 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $396 |
| Trazodone Hcl | 51 | $381 |
| Methadone Hcl | 32 | $330 |
| Eszopiclone | 44 | $315 |
| Gabapentin | 32 | $310 |
| Methylphenidate Hcl | 15 | $238 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 22 | $129 |
| Zolpidem Tartrate | 22 | $42 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Sunosi | $497 | $16,17219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.
Other family in Dublin
- Adrienne YanichDublin$81K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.